# Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

> **NCT02560311** · — · UNKNOWN · sponsor: **University of Zurich** · enrollment: 100 (estimated)

## Conditions studied

- ERBB2
- Breast Cancer
- Metastatic Neoplasm

## Interventions

- **OTHER:** observation

## Key facts

- **NCT ID:** NCT02560311
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2015-09
- **Final completion:** 2016-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02560311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02560311, "Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02560311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*